This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Rheumatology
Rheumatology
Ablynx’s anti-IL-6R Nnanobody shows excellent 24 week safety and efficacy results
Positive CHMP opinion for Ilaris®
Subcutaneous formulation of ORENCIA® approved by European Commission
Adalimumab approved in EU for some spondyloarthritis
Cost effectiveness of TNF-alpha inhibitors in RA
Cost effectiveness of TNF-alpha inhibitors in RA
Apremilast reaches significance in psoriatic arthritis
EULAR: Canakinumab ‘option for severe childhood arthritis’
Pfizer’s new RA drug backed for FDA approval
Certolizumab pegol shows AxSpaA efficacy in Phase III
Pharmacoeconomics of subcutaneous methotrexate
Small molecule inhibitors for the treatment of RA
« Previous
1
…
8
9
10
11
12
…
31
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: